Wonik Corporation (KOSDAQ:032940)
South Korea · Delayed Price · Currency is KRW 11,870
-350 (-2.86%)
At close: Feb 27, 2026
Wonik Market Cap
Wonik has a market cap or net worth of 215.95 billion as of February 27, 2026. Its market cap has increased by 264.67% in one year.
Market Cap
215.95B
Enterprise Value
265.45B
Revenue
149.96B
Ranking
n/a
PE Ratio
7.34
Stock Price
11,870.00
Market Cap Chart
Since September 14, 2000, Wonik's market cap has increased from 74.70B to 215.95B, an increase of 189.09%. That is a compound annual growth rate of 4.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 215.95B | 12.19% |
| Dec 30, 2025 | 192.48B | 212.56% |
| Dec 30, 2024 | 61.58B | -7.39% |
| Dec 28, 2023 | 66.50B | -7.70% |
| Dec 29, 2022 | 72.04B | -10.00% |
| Dec 30, 2021 | 80.05B | -7.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ace Technologies | 219.98B |
| ISU Abxis | 219.48B |
| Avaco | 218.82B |
| HLB Pharmaceutical | 217.80B |
| Prestige Biologics | 217.32B |
| FLITTO | 217.05B |
| Bio Solution | 216.34B |
| Vaxcell-Bio Therapeutics | 215.83B |